Shares of IntriCon IIN were flat in after-market trading after the company reported Q4 results.
Quarterly Results
Earnings per share rose 50.00% year over year to $0.12, which beat the estimate of $0.04.
Revenue of $30,301,000 rose by 9.41% year over year, which beat the estimate of $27,350,000.
Outlook
Earnings guidance hasn't been issued by the company for now.
Revenue guidance hasn't been issued by the company for now.
How To Listen To The Conference Call
Date: Feb 25, 2021
Time: 05:00 PM
ET Webcast URL: https://edge.media-server.com/mmc/p/y6bpms6j
Technicals
52-week high: $23.18
52-week low: $9.84
Price action over last quarter: Up 45.46%
Company Description
IntriCon Corp design, develop and manufacture miniature and micro-miniature body-worn medical and electronics products. The company has two operating segments, the Body-Worn Device segment (consisting of three markets: medical, hearing health, and professional audio), and the Hearing Health Direct-to-Consumer segment. Its primary geographic markets are the United States, Europe, Asia, and all other countries. The company serves a diverse range of markets including the hearing healthcare market, the medical biotelemetry market, and the professional audio communication market.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.